We offer a comprehensive range of support services to better help healthcare professionals to deliver optimised ECP immunomodulation to patients.

Education and knowledge
sharing tailored to HCPs.

Patients and funding access
support for the future of ECP Immunomodulation.

Scientific and clinical
partnerships with leading experts from around the world.

Comprehensive customer
support to ensure optimised
patient treatment.
References:
1. Therakos, Inc. Operator’s Manual. THERAKOS™ CELLEX™ Photopheresis System. 2. Hart JW, et al. Ther Adv Hematol. 2013;4:320-334. 3. Wang L, et al. Front Immunol. 2018;9:2207. 4. Ni M, et al. Front Immunol. 2019;10:547. 5. Mankarious M, et al. Front Immunol. 2020;11:81. 6. Dignan FL, et al. Bone Marrow Transplant. 2014;49(5):704-708. 7. Flowers ME, et al. Blood. 2008;112(7):2667-2674. 8. Yoo EK, et al. J Invest Dermatol. 1996;107:235-242. 9. Morelli AE, et al. Blood. 2003;101:611-620. 10. Craciun LI, et al. Transplantation. 2002;74:995-1000. 11. Lamioni A, et al. Transplantation. 2005;79:846-850.